Life sciences company Quick-Med Technologies has received notice of allowance for additional new US patent protecting new, non-leaching Nimbus antimicrobial technology. A total of 41 claims were allowed by the US Patent and Trademark ...
Quick-Med Technologies, a US-based life sciences company, obtained a notice-of-allowance for a new US patent covering Nimbus, its antimicrobial technology custom designed for wound care and other medical applications. The U.S. Patent and ...
Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has been awarded a contract by the U.S. Department of Defense ...
Tags: Textile, Med Technologies, Scar Contracture
The US Patent and Trademark Office (USPTO) has granted tenth US patent to Quick-Med Technologies' non-leaching NIMBUS antimicrobial technology, designed for use in wound care and other medical applications. The patent, which is entitled ...
Tags: US Patent, USPTO, NIMBUS, antimicrobial technology
Derma Sciences has acquired exclusive rights of Quick-Med Technologies' intellectual property related to the Nimbus antimicrobial technology, available in Bioguard dressings. The FDA cleared Nimbus is a non-toxic, long-lasting ...
Tags: Derma Sciences, Quick-Med Technologies, Nimbus antimicrobial technology
The Australian Patent Office and the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial, have granted new patents to Quick-Med Technologies' polyurethane-modified polycation, a new product of the NIMBUS technology family ...
Tags: patent, polyurethane modified polycation, antimicrobial